Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
about
Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective ImmunityComparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal deliveryClassical Flt3L-dependent dendritic cells control immunity to protein vaccineNovel immune-modulator identified by a rapid, functional screen of the parapoxvirus ovis (Orf virus) genome.Langerhans cells and dermal dendritic cells capture protein antigens in the skin: possible targets for vaccination through the skin.Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing.Intradermal immunization with wall teichoic acid (WTA) elicits and augments an anti-WTA IgG response that protects mice from methicillin-resistant Staphylococcus aureus infection independent of mannose-binding lectin statusLaser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling.High-level cellular and humoral immune responses in Guinea pigs immunized intradermally with a heat-inactivated varicella-zoster virus vaccineDNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response.Topical application of marine briarane-type diterpenes effectively inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and dermatitis in murine skin.Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responsesMicroneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression.Specialized role of migratory dendritic cells in peripheral tolerance induction.Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates.LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunityMechanisms by which chronic ethanol feeding impairs the migratory capacity of cutaneous dendritic cellsLangerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.Targeting skin dendritic cells to improve intradermal vaccination.Harnessing dendritic cells in inflammatory skin diseases.Cutaneous dendritic cells in allergic inflammation.Dendritic cell-targeted vaccines.Potent induction of antibody-secreting B cells by human dermal-derived CD14+ dendritic cells triggered by dual TLR ligation.Solid-in-oil nanodispersions for transdermal drug delivery systems.Treatment with GM-CSF secreting myeloid leukemia cell vaccine prior to autologous-BMT improves the survival of leukemia-challenged miceThe Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system?CD34+ -derived Langerhans cell-like cells are different from epidermal Langerhans cells in their response to thymic stromal lymphopoietinLangerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells.Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunityIL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.Non-human papillomaviruses for gene delivery in vitro and in vivo.
P2860
Q27312070-CDBD7B18-9384-4728-84CB-B887970870BBQ33603206-1F75FBAF-BFA0-48C4-B744-9DE6604F3CF9Q34089167-EB5AD299-8B63-491E-A66A-66F9DF7509F4Q34127421-2845AB04-7971-4D91-8D6E-E7A2B4D4B883Q34130289-8AF91198-E483-4C47-96AC-726C3925F5C0Q34608010-6A0978F9-5B84-47E5-8A24-9F12BB7AF875Q34924567-0C8BF5EC-720D-4DBB-8C3D-F8346B15BB89Q35132732-D27AF36F-6D3A-4990-8E40-499792F3EE67Q35138155-884C0146-41E5-49F1-80DE-3BEE73CCEE3AQ35237489-56AD7487-AD0E-4418-9086-B8603141C4C9Q35548072-CF0BE642-2147-440B-B347-CEE1C306509DQ35655963-AC32C716-A056-4148-B722-B474BD82DBD5Q35682993-60E6994E-EBC7-4392-B94F-D2BC27AC35A4Q35785681-B5E68930-75ED-400F-BB32-E4EDAC50A3C7Q36077060-3857B9D6-5143-4078-B1E8-8ACF42182A54Q36580331-E0B9E93D-EB9B-4FD6-8B0C-F52C1A2EAD7BQ36654119-7EA484E2-9AA6-4AC5-AC35-D51A1B899CE0Q36830663-A6BEC711-FEE2-4368-953D-494C3355DF3EQ37066634-BA679727-997B-435A-ABAC-9591FD9EA092Q37273925-E5BACD29-384B-42D9-8892-756C41E0C21DQ37622952-D59607BB-3978-4F52-A922-AA4B7B268306Q37643323-7C556862-93FA-454E-8DC9-FABDA5CE94EAQ37831193-507D3A21-D276-4E2A-BBCE-ADA4267AD8EFQ37835969-C8FFBC9A-B7DE-4B3E-B5FD-D56CC62BA028Q38026993-B2E52274-6314-4637-9456-88CE3589CE70Q38218671-B8CC6211-8ED7-4C37-B360-137C0DFEBC8FQ38258468-A7416129-341F-46B5-BADE-6678264DC280Q38830870-3365C7B4-5385-4CA5-A170-63C5C3CA8AFCQ39644103-A9DCE507-1043-418E-B755-83B07EBA8137Q39882251-65E8A76A-D881-4412-994B-EBDEA6A6D380Q41858037-B953FA7E-4138-4093-844B-CA240499E938Q41888907-B4B395EA-D5B0-4D1D-A4B0-59E05ED4BACCQ42147428-63417F40-AFAA-4433-814D-F02D2FA3B7E6Q54530047-30635688-F21D-448D-BABA-1092F5D174B9Q55415533-CA643F22-9A6C-47ED-9575-8EA75D747BE1
P2860
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@ast
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@en
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@nl
type
label
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@ast
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@en
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@nl
prefLabel
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@ast
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@en
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@nl
P2860
P50
P356
P1476
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
@en
P2093
Juliana Idoyaga
Ralph M Steinman
P2860
P304
P356
10.1038/ICB.2010.39
P577
2010-04-06T00:00:00Z